Prabir Jha, President & Global Chief People Officer of Cipla, shares his insights on the evolution of careers from titles to experiences.

YouTube-Deloitte US

Stocks On The Move | Cipla slips over 3% in trade as details of the US FDA warning letter dated Nov 18 for its Pithampur unit highlight data ...

YouTube-CNBC-TV18

FromTheArchives presenting to you, #TheCiplaStory The seed of Caring for Life was sown in 1935, with our founder Dr K.A. Hamied's vision of ...

YouTube-Cipla

One of India's most respected companies, which has made generic drugs at affordable prices, could be on the verge of a significant shift.

YouTube-CNBC-TV18

CNBC-TV18 Exclusive | Samina Hamied steps down as the Executive Vice Chairperson of Cipla. Management tells CNBC-TV18.

YouTube-CNBC-TV18

India produces over 30% of the world's entire supply of generic drugs. Cipla is one of India's largest drug manufacturers.

YouTube-Chemical & Engineering News

Share your videos with friends, family, and the world.

YouTube-Cipla

Shares of Cipla Ltd. rose on Wednesday after its promoters, Shirin Hamied, Rumana Hamied, Samina Hamied, and Okasa Pharma Pvt. sold stake in ...

YouTube-moneycontrol

Cipla receives final approval for the generic version of Somatuline® Depot (lanreotide) Injection 120 mg/ 0.5 mL, 90 mg/0.3 mL, 60 mg/0.2 mL for ...

Instagram

CNBC-TV18 Exclusive | Doesn't seem like Cipla is a part of any transaction: Cipla CEO Umang Vohra maintains that news surrounding a ...

YouTube-CNBC-TV18

Cipla's Q4 margin & EBITDA miss estimates. US sales at $226 m vs CNBC-TV18 poll of $228-230 m. Foram Parekh of Sharekhan and Prakash Diwan, ...

YouTube-CNBC-TV18

Race For Cipla Hots Up | There seems to be a new contender in the race for Cipla. After Torrent Pharma, reports now suggest PE Firm Bain ...

YouTube-CNBC-TV18

FutureFemaleForward | Reports suggest that women make up just about 11% of the pharma industry. But Cipla is targeting 20% gender diversity ...

YouTube-CNBC-TV18

Cipla reports a miss on revenue & EBITDA estimates in its Q4FY24 numbers, The company's CEO Umang Vohra speaks on on the quarter gone by.

YouTube-CNBC-TV18

Here's Nikunj Dalmia's take #Cipla #StocksInNews #ETNOWNews #stockstowatch #businessnewss. How will promoters' 2.53% ...

Facebook-ET NOW

The commitment to high quality standards has made Cipla the most trusted brand among healthcare professionals.

YouTube-Cipla

In this segment of 'The Medicine Box', Cipla CEO Umang Vohra discusses the introduction of weight loss drug Semaglutide in the Indian ...

YouTube-CNBC-TV18

Buzzing Stocks | Cipla is the top Nifty gainer this morning after reporting a strong set of Q3FY24 earnings. Ekta Batra with the details.

YouTube-CNBC-TV18

Cipla is the top Nifty gainer today, gaining over 3%. Investec initiates a coverage on the stock with a target price of ₹1550.

YouTube-CNBC-TV18

Sanofi India gains on entering into an exclusive partnership with Cipla where Cipla will distribute six brands of Sanofi India's Central ...

YouTube-CNBC-TV18